Projekt
ECARA
Abgeschlossen · 2017 bis 2019
Rickli Hans, Gemperle Michaela
Art
Klinische Forschung
Reichweite
Multizentrisch, KSSG als teilnehmendes Zentrum
Bereiche
Status
Abgeschlossen
Start
2017
Ende
2019
Finanzierungsart
Industrie
Studiendesign
Describe lipid parameters in patients on Evolocumab at
baseline and over 12 months in an observational real
world setting. Maintenance of LDL-c reduction over the
study period serves as surrogate for persistence with
therapy and informs us about the utility of a bi-weekly or
monthly SC application in clinical practice
Kurzbeschreibung/Zielsetzung
Explore Clinical Utility of Evolocumab in Combination with
an e-Health System: Swiss Prospective Observational
Study in Patients with clinical Atherosclerotic
Cardiovascular Disease (ASCVD) (ECARA)